Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval
about
Updosing of Nonsedating Anti-histamines in Recalcitrant Chronic UrticariaA review of the second-generation antihistamine ebastine for the treatment of allergic disordersIncidence and risk of QTc interval prolongation among cancer patients treated with vandetanib: a systematic review and meta-analysisCardiovascular safety of antihistamines.Co-administration of ketoconazole with H1-antagonists ebastine and loratadine in healthy subjects: pharmacokinetic and pharmacodynamic effects.Ebastine in the light of CONGA recommendations for the development of third-generation antihistaminesEbastine in chronic spontaneous urticaria in higher dosesNon-antiarrhythmic drugs prolonging the QT interval: considerable use in seven countries.Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN).Ebastine overdose in a childEffects of supratherapeutic doses of ebastine and terfenadine on the QT interval.Itraconazole and rifampin alter significantly the disposition and antihistamine effect of ebastine and its metabolites in healthy participants.Ebastine inhibits T cell migration, production of Th2-type cytokines and proinflammatory cytokines.Slow QT interval adaptation to heart rate changes in normal ambulatory subjects.
P2860
Q26747012-4B4EABA8-3A24-452D-AAD9-20DB01CCC1F5Q28272998-B76EC3B2-0B16-4283-8AA6-B38088FD9D18Q28480930-264DBCB2-47FD-4AAD-B03E-7D99BE25670FQ33955706-B741486C-5892-4B7F-93C1-5EBB2DAD8B6AQ34555779-5EA7DB26-5E8B-4538-9656-790C31D4E32DQ34623813-17A7E496-925F-4A43-981C-82ED4E9A5E44Q34633950-18BDD53F-E28B-41BC-85BB-D532471D8A59Q34808260-1552E420-C3DC-4260-A960-524A4C1CD571Q36570549-D95D7509-DEFC-41EE-8188-8614D796F39FQ42292941-4D7BE061-1511-487F-80FB-EA1AB523CD41Q42780024-E3DA4DA8-C1D2-4298-8028-01070A991154Q43258643-7869B00E-3C90-4756-9468-F73F36657ABDQ44655330-BB5A5C48-9882-424D-AF90-0BF327743F73Q47253777-2769A4A7-06DC-41D0-8E90-7AB182F5A037
P2860
Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval
@ast
Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval
@en
Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval
@nl
type
label
Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval
@ast
Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval
@en
Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval
@nl
prefLabel
Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval
@ast
Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval
@en
Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval
@nl
P2093
P2860
P3181
P1476
Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval
@en
P2093
J Morganroth
M S Gillen
P2860
P3181
P356
10.1046/J.0306-5251.2001.01345.X
P407
P577
2001-08-01T00:00:00Z